Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kefalas S.A. is a Greek pharmaceutical company founded in 1974 that focuses on the development, manufacturing, and distribution of pharmaceutical products. The company operates as a key representative for international pharmaceutical manufacturers in the Greek market while also maintaining a portfolio of its own generic medications. Its therapeutic focus includes the central nervous system, cardiovascular health, and gastroenterology. Headquartered in Metamorfosi, Greece, Kefalas leverages a comprehensive distribution network to supply hospitals and pharmacies across the country. The firm is recognized for its long-standing presence in the Hellenic healthcare sector and its adherence to high-quality manufacturing standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kefalas.